Skip to main content
AmigoFish

Episode 527: ESMO 2026 - DASL-HiCaP Adding Darolutamide to ADT and XRT in High-risk Localized Prostate Cancer

From The Uromigos · · 38 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Chris Sweeney discusses this ANZUP trial which adds more phase 3 data to the high risk prostate cancer space.

Back to The Uromigos · Report a problem